Effektivitet og tolerabilitet af ABT-869 versus Sorafenib i avanceret hepatocellulært karcinom (HCC)
Et åbent, randomiseret fase 3-studie af effektiviteten og tolerabiliteten af linifanib (ABT-869) versus sorafenib hos forsøgspersoner med avanceret hepatocellulært karcinom (HCC)
Studieoversigt
Status
Status
Betingelser
Betingelser
- Leversygdomme
- Sygdomme i fordøjelsessystemet
- Neoplasmer
- Neoplasmer efter histologisk type
- Neoplasmer efter sted
- Adenocarcinom
- Karcinom
- Neoplasmer, kirtel og epitel
- Neoplasmer i fordøjelsessystemet
- Carcinom, hepatocellulært
- Neoplasmer i leveren
- Hepatocellulært karcinom Ikke-operabelt
- Tilbagevendende hepatocellulært karcinom
Intervention / Behandling
Intervention / Behandling
Detaljeret beskrivelse
Undersøgelsestype
Undersøgelsestype
Tilmelding (Faktiske)
Tilmelding
Fase
Fase
- Fase 3
Kontakter og lokationer
Studiesteder
-
-
-
Buenos Aires, Argentina, B1629ODT
- Site Reference ID/Investigator# 35705
-
Rosario, Santa Fe, Argentina, S2002KDS
- Site Reference ID/Investigator# 35702
-
-
-
-
-
Camperdown, Australien, 2050
- Site Reference ID/Investigator# 23152
-
Concord, Australien, 2139
- Site Reference ID/Investigator# 23150
-
Kingswood, Australien, 2747
- Site Reference ID/Investigator# 27122
-
Kogarah, Australien, 2217
- Site Reference ID/Investigator# 23153
-
Southport, Australien, 4215
- Site Reference ID/Investigator# 24103
-
-
-
-
-
Brussels, Belgien, 1070
- Site Reference ID/Investigator# 38902
-
Brussels, Belgien, 1200
- Site Reference ID/Investigator# 23162
-
Edegem, Belgien, 2650
- Site Reference ID/Investigator# 23843
-
Ghent, Belgien, 9000
- Site Reference ID/Investigator# 23161
-
Gilly, Belgien, 6060
- Site Reference ID/Investigator# 23842
-
Leuven, Belgien, 3000
- Site Reference ID/Investigator# 23163
-
-
-
-
-
Edmonton, Canada, T6G 2X8
- Site Reference ID/Investigator# 26702
-
Halifax, Canada, B3H 2Y9
- Site Reference ID/Investigator# 25482
-
Montreal, Canada, H2X 3J4
- Site Reference ID/Investigator# 39614
-
Ottawa, Canada, K1H 8L6
- Site Reference ID/Investigator# 23184
-
Sherbrooke, Canada, J1G 2E8
- Site Reference ID/Investigator# 23183
-
Toronto, Canada, M4C 3E7
- Site Reference ID/Investigator# 24522
-
-
-
-
-
Temuco, Chile, 01745
- Site Reference ID/Investigator# 36967
-
Vina del Mar, Chile
- Site Reference ID/Investigator# 36964
-
-
-
-
-
Aarhus C, Danmark, 8000
- Site Reference ID/Investigator# 23442
-
-
-
-
-
Chelyabinsk, Den Russiske Føderation, 454087
- Site Reference ID/Investigator# 43202
-
Kazan, Den Russiske Føderation, 420029
- Site Reference ID/Investigator# 43203
-
Moscow, Den Russiske Føderation, 115478
- Site Reference ID/Investigator# 23462
-
Moscow, Den Russiske Føderation, 115478
- Site Reference ID/Investigator# 23849
-
-
-
-
-
Alexandria, Egypten, 21131
- Site Reference ID/Investigator# 23198
-
Cairo, Egypten, 11796
- Site Reference ID/Investigator# 23199
-
-
-
-
California
-
Beverly Hills, California, Forenede Stater, 90211-1850
- Site Reference ID/Investigator# 23247
-
LaVerne, California, Forenede Stater, 91750
- Site Reference ID/Investigator# 23608
-
Orange, California, Forenede Stater, 92868
- Site Reference ID/Investigator# 23852
-
Orange, California, Forenede Stater, 92868
- Site Reference ID/Investigator# 40162
-
-
Delaware
-
Newark, Delaware, Forenede Stater, 19713
- Site Reference ID/Investigator# 23254
-
-
Georgia
-
Gainesville, Georgia, Forenede Stater, 30505
- Site Reference ID/Investigator# 23253
-
-
Hawaii
-
Honolulu, Hawaii, Forenede Stater, 96813
- Site Reference ID/Investigator# 23609
-
Honolulu, Hawaii, Forenede Stater, 96819
- Site Reference ID/Investigator# 24848
-
-
Kentucky
-
Louisville, Kentucky, Forenede Stater, 40202
- Site Reference ID/Investigator# 23250
-
-
Missouri
-
St. Louis, Missouri, Forenede Stater, 63104
- Site Reference ID/Investigator# 23257
-
-
Nevada
-
Las Vegas, Nevada, Forenede Stater, 89135
- Site Reference ID/Investigator# 23603
-
-
North Carolina
-
Durham, North Carolina, Forenede Stater, 27710
- Site Reference ID/Investigator# 23244
-
-
Oregon
-
Portland, Oregon, Forenede Stater, 97213
- Site Reference ID/Investigator# 23252
-
-
-
-
-
Amiens, Frankrig, 80054
- Site Reference ID/Investigator# 43302
-
Clichy, Frankrig, 92118
- Site Reference ID/Investigator# 23201
-
Creteil, Frankrig, 94010
- Site Reference ID/Investigator# 43144
-
Lille Cedex, Frankrig, 59037
- Site Reference ID/Investigator# 23200
-
Paris Cedex 12, Frankrig, 75571
- Site Reference ID/Investigator# 23168
-
Paris Cedex 13, Frankrig, 75651
- Site Reference ID/Investigator# 40623
-
Rouen Cedex, Frankrig, 76031
- Site Reference ID/Investigator# 28345
-
Strasbourg Cedex, Frankrig, 67091
- Site Reference ID/Investigator# 23165
-
Vandoeuvre Les Nancy, Frankrig, 54511
- Site Reference ID/Investigator# 28347
-
-
-
-
-
Athens, Grækenland, 115 27
- Site Reference ID/Investigator# 24525
-
-
-
-
-
Amsterdam, Holland, 1081 HV
- Site Reference ID/Investigator# 23272
-
Amsterdam, Holland, 1105 AZ
- Site Reference ID/Investigator# 23270
-
Rotterdam, Holland, 3015 CE
- Site Reference ID/Investigator# 24782
-
-
-
-
-
Hong Kong, Hong Kong
- Site Reference ID/Investigator# 24980
-
-
-
-
-
Benevento, Italien, 82100
- Site Reference ID/Investigator# 27998
-
Milan, Italien, 20122
- Site Reference ID/Investigator# 23424
-
Milan, Italien, 20132
- Site Reference ID/Investigator# 41488
-
Palermo, Italien, 90127
- Site Reference ID/Investigator# 23425
-
Pavia, Italien, 27100
- Site Reference ID/Investigator# 41542
-
Rome, Italien, 00144
- Site Reference ID/Investigator# 23428
-
Rome, Italien, 00168
- Site Reference ID/Investigator# 24042
-
-
-
-
-
Aichi, Japan
- Site Reference ID/Investigator# 26506
-
Chiba, Japan
- Site Reference ID/Investigator# 36308
-
Chiba, Japan
- Site Reference ID/Investigator# 37602
-
Fukuoka, Japan
- Site Reference ID/Investigator# 29758
-
Hokkaido, Japan
- Site Reference ID/Investigator# 37603
-
Ibaraki-ken, Japan
- Site Reference ID/Investigator# 28189
-
Kanazawa, Japan
- Site Reference ID/Investigator# 26505
-
Kumamoto, Japan
- Site Reference ID/Investigator# 29757
-
Kurume, Japan
- Site Reference ID/Investigator# 27343
-
Matsuyama-city, Japan
- Site Reference ID/Investigator# 29759
-
Osaka, Japan
- Site Reference ID/Investigator# 26507
-
Osaka, Japan
- Site Reference ID/Investigator# 27959
-
Osakasayama, Japan
- Site Reference ID/Investigator# 26508
-
Shimotsuke, Japan
- Site Reference ID/Investigator# 29756
-
Shizuoka, Japan
- Site Reference ID/Investigator# 36782
-
Tochigi-ken, Japan
- Site Reference ID/Investigator# 28187
-
Tokyo, Japan
- Site Reference ID/Investigator# 26503
-
Tokyo, Japan
- Site Reference ID/Investigator# 27242
-
Yokohama City, Japan
- Site Reference ID/Investigator# 26504
-
Yufu, Japan
- Site Reference ID/Investigator# 26509
-
-
-
-
-
Beijing, Kina, 100071
- Site Reference ID/Investigator# 23186
-
Changchun, Kina, 130012
- Site Reference ID/Investigator# 43443
-
Chengdu, Kina, 610041
- Site Reference ID/Investigator# 23194
-
Chongqing, Kina, 400038
- Site Reference ID/Investigator# 43442
-
Dalian, Kina, 116011
- Site Reference ID/Investigator# 44444
-
Fuzhou, Kina, 350025
- Site Reference ID/Investigator# 43444
-
Guangzhou City, Kina, 510515
- Site Reference ID/Investigator# 43482
-
Hangzhou, Kina, 310016
- Site Reference ID/Investigator# 42563
-
Harbin, Kina, 150081
- Site Reference ID/Investigator# 44443
-
Jinan, Kina, 250031
- Site Reference ID/Investigator# 44062
-
Nanjing City, Kina, 210002
- Site Reference ID/Investigator# 23191
-
Nanning City, Kina, 530021
- Site Reference ID/Investigator# 44063
-
Qingdao, Kina, 266003
- Site Reference ID/Investigator# 42817
-
Shanghai, Kina, 200032
- Site Reference ID/Investigator# 40624
-
Shanghai, Kina, 200080
- Site Reference ID/Investigator# 23189
-
Suzhou, Kina, 215006
- Site Reference ID/Investigator# 40448
-
Xian, Kina, 710032
- Site Reference ID/Investigator# 23190
-
-
-
-
-
Busan, Korea, Republikken, 602-715
- Site Reference ID/Investigator# 23447
-
Busan, Korea, Republikken, 614-735
- Site Reference ID/Investigator# 39003
-
Busan, Korea, Republikken, 626-770
- Site Reference ID/Investigator# 23445
-
Daegu, Korea, Republikken, 700-721
- Site Reference ID/Investigator# 23444
-
Gyeonggi-do, Korea, Republikken, 410-769
- Site Reference ID/Investigator# 26543
-
Jeollanam-do, Korea, Republikken, 519-809
- Site Reference ID/Investigator# 23457
-
Jeonju-si, Korea, Republikken, 561-712
- Site Reference ID/Investigator# 39002
-
Seoul, Korea, Republikken, 120-752
- Site Reference ID/Investigator# 23454
-
Seoul, Korea, Republikken, 138-701
- Site Reference ID/Investigator# 25562
-
Seoul, Korea, Republikken, 138-736
- Site Reference ID/Investigator# 23449
-
Seoul, Korea, Republikken, 152-703
- Site Reference ID/Investigator# 23456
-
Suwon-si, Korea, Republikken, 443-721
- Site Reference ID/Investigator# 23450
-
-
-
-
-
Kuala Lumpur, Malaysia, 50603
- Site Reference ID/Investigator# 23460
-
Penang, Malaysia, 11200
- Site Reference ID/Investigator# 23461
-
Petaling Jaya, Selangor, Malaysia, 46050
- Site Reference ID/Investigator# 23459
-
-
-
-
-
Durango, DGO., Mexico, CP 34000
- Site Reference ID/Investigator# 23155
-
Monterrey, NL, Mexico, CP 64000
- Site Reference ID/Investigator# 43102
-
Monterrey, NL, Mexico, CP 64020
- Site Reference ID/Investigator# 43145
-
-
-
-
-
Auckland, New Zealand, 1142
- Site Reference ID/Investigator# 23160
-
-
-
-
-
Oslo, Norge, 0407
- Site Reference ID/Investigator# 23846
-
-
-
-
-
Ponce, Puerto Rico, 00716
- Site Reference ID/Investigator# 42706
-
San Juan, Puerto Rico, 00936-5067
- Site Reference ID/Investigator# 42705
-
-
-
-
-
Baia Mare, Rumænien, 430031
- Site Reference ID/Investigator# 33979
-
Bucharest, Rumænien, 022328
- Site Reference ID/Investigator# 33344
-
Cluj Napoca, Rumænien, 400015
- Site Reference ID/Investigator# 33343
-
Craiova, Rumænien, 200385
- Site Reference ID/Investigator# 33977
-
Iasi, Rumænien, 700106
- Site Reference ID/Investigator# 33345
-
Oradea, Rumænien, 410469
- Site Reference ID/Investigator# 33346
-
-
-
-
-
Singapore, Singapore, 119228
- Site Reference ID/Investigator# 23159
-
Singapore, Singapore, 169610
- Site Reference ID/Investigator# 23158
-
-
-
-
-
A Coruna, Spanien, 15006
- Site Reference ID/Investigator# 23466
-
Madrid, Spanien, 28007
- Site Reference ID/Investigator# 26063
-
Madrid, Spanien, 28033
- Site Reference ID/Investigator# 40931
-
Madrid, Spanien, 28034
- Site Reference ID/Investigator# 23465
-
Madrid, Spanien, 28050
- Site Reference ID/Investigator# 23463
-
Santander, Spanien, 39008
- Site Reference ID/Investigator# 23467
-
Zaragoza, Spanien, 50009
- Site Reference ID/Investigator# 23468
-
-
-
-
-
Changhua City, Taiwan, 500
- Site Reference ID/Investigator# 23475
-
Kaohsiung County, Taiwan, 833
- Site Reference ID/Investigator# 23472
-
Taichung, Taiwan, 40705
- Site Reference ID/Investigator# 23474
-
Taichung City, Taiwan, 404
- Site Reference ID/Investigator# 25262
-
Tainan, Taiwan, 704
- Site Reference ID/Investigator# 23476
-
Tainan, Taiwan, 710
- Site Reference ID/Investigator# 23478
-
Tainan, Taiwan, 736
- Site Reference ID/Investigator# 23477
-
Taipei, Taiwan, 110
- Site Reference ID/Investigator# 43237
-
Taipei, Taiwan, 112
- Site Reference ID/Investigator# 23473
-
Taipei, Taiwan
- Site Reference ID/Investigator# 23469
-
Taipei City, Taiwan, 10449
- Site Reference ID/Investigator# 23470
-
Taoyuan, Taiwan, 333
- Site Reference ID/Investigator# 23471
-
-
-
-
-
Brno, Tjekkiet, 625 00
- Site Reference ID/Investigator# 23167
-
Olomouc, Tjekkiet, 775 20
- Site Reference ID/Investigator# 23166
-
Prague 2, Tjekkiet, 12808
- Site Reference ID/Investigator# 24523
-
Prague 4, Tjekkiet, 14021
- Site Reference ID/Investigator# 23844
-
Prague 8, Tjekkiet, 18081
- Site Reference ID/Investigator# 40930
-
Usti nad Labem, Tjekkiet, 401 13
- Site Reference ID/Investigator# 23197
-
-
-
-
-
Berlin, Tyskland, 13353
- Site Reference ID/Investigator# 23267
-
Bochum, Tyskland, 44789
- Site Reference ID/Investigator# 23845
-
Frankfurt am Main, Tyskland, 60590
- Site Reference ID/Investigator# 23266
-
Freiburg, Tyskland, 79106
- Site Reference ID/Investigator# 23268
-
Mainz, Tyskland, 55131
- Site Reference ID/Investigator# 23269
-
-
-
-
-
Graz, Østrig, 8036
- Site Reference ID/Investigator# 27968
-
Innsbruck, Østrig, A-6020
- Site Reference ID/Investigator# 27969
-
Linz, Østrig, 4020
- Site Reference ID/Investigator# 27970
-
Vienna, Østrig, 1090
- Site Reference ID/Investigator# 27967
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inklusionskriterier
- Histologisk eller cytologisk diagnose med inoperabel eller metastatisk HCC
- Child Pugh klasse A
- ECOG ydeevne status 0-1
- Tilstrækkelig hæmatologisk, lever- og nyrefunktion
Eksklusionskriterier
- Forudgående systemisk (indgivet intravenøst eller oralt snarere end lokoregionalt) behandling for HCC
- Forudgående lokal terapi (inklusive leverstyret terapi) inden for 4 uger fra indtræden
- Ubehandlede hjerne- eller meningeale metastaser
- Nuværende behandling i et andet klinisk forsøg
- Graviditet eller amning
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Aktiv komparator: Sorafenib
|
Tabletter, orale, 400 mg, to gange dagligt, indtil sygdomsprogression eller uacceptabel toksicitet.
|
|
Eksperimentel: ABT-869
|
Tabletter, orale, 17,5 mg, én gang dagligt, indtil sygdomsprogression eller uacceptabel toksicitet
|
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Samlet overlevelse
Tidsramme: Fra randomisering til patientens død; vurderes månedligt
|
Fra randomisering til patientens død; vurderes månedligt
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Tid til Progression (TTP)
Tidsramme: Fra randomisering til patientprogression; vurderes hver 6. uge
|
Fra randomisering til patientprogression; vurderes hver 6. uge
|
|
Samlet responsrate (ORR)
Tidsramme: Vurderes hver 6. uge
|
Vurderes hver 6. uge
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Efterforskere
Efterforskere
- Studieleder: Justin Ricker, MD, Abbott
Publikationer og nyttige links
Generelle publikationer
- Kolamunnage-Dona R, Berhane S, Potts H, Williams EH, Tanner J, Janowitz T, Hoare M, Johnson P. Sorafenib is associated with a reduced rate of tumour growth and liver function deterioration in HCV-induced hepatocellular carcinoma. J Hepatol. 2021 Oct;75(4):879-887. doi: 10.1016/j.jhep.2021.05.015. Epub 2021 May 27.
- Cainap C, Qin S, Huang WT, Chung IJ, Pan H, Cheng Y, Kudo M, Kang YK, Chen PJ, Toh HC, Gorbunova V, Eskens FA, Qian J, McKee MD, Ricker JL, Carlson DM, El-Nowiem S. Linifanib versus Sorafenib in patients with advanced hepatocellular carcinoma: results of a randomized phase III trial. J Clin Oncol. 2015 Jan 10;33(2):172-9. doi: 10.1200/JCO.2013.54.3298. Epub 2014 Dec 8. Erratum In: J Clin Oncol. 2017 Aug 1;35(22):2590.
Datoer for undersøgelser
Studer store datoer
Studiestart
Studiestart
Primær færdiggørelse (Faktiske)
Primær færdiggørelse
Studieafslutning (Faktiske)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
- Adenocarcinom
- Leversygdomme
- Neoplasmer
- Karcinom
- Carcinom, hepatocellulært
- Gastrointestinale sygdomme
- Sygdomme i fordøjelsessystemet
- Gastrointestinale neoplasmer
- Neoplasmer i fordøjelsessystemet
- Neoplasmer i leveren
- Neoplasmer, kirtel og epitel
- Neoplasmer efter sted
- Neoplasmer efter histologisk type
- Molekylære mekanismer for farmakologisk virkning
- Enzymhæmmere
- Antineoplastiske midler
- Proteinkinasehæmmere
- Sorafenib
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- M10-963
- 2009-013435-38 (EudraCT nummer)
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .